(Q42637640)

4 November 2017

title

Correlation between selected prognostic factors and postoperative course in liver transplant recipients (English)

1 reference

4 November 2017

W Patkowski

1

1 reference

4 November 2017

K Zieniewicz

series ordinal

2

1 reference

4 November 2017

M Skalski

series ordinal

3

1 reference

4 November 2017

M Krawczyk

series ordinal

4

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

Transplantation Proceedings

4 November 2017

published in

1 reference

4 November 2017

volume

41

1 reference

4 November 2017

issue

8

1 reference

4 November 2017

page(s)

3091-3102

1 reference

Compensated cirrhosis: Natural history and prognostic factors

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

A comparison of disease severity and survival rates after liver transplantation in the United Kingdom, Canada, and the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Intra-abdominal surgery in patients with advanced cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Transection of the oesophagus for bleeding oesophageal varices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

The survival benefit of liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

The long-term survival and causes of death in patients who survive at least 1 year after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Model for end-stage liver disease (MELD) exception guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

MELD score predicts 1-year patient survival post-orthotopic liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

MELD fails to measure quality of life in liver transplant candidates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the s

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

The new liver allocation system: moving toward evidence-based transplantation policy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Does MELD work for relisted candidates?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

A model to predict survival at one month, one year, and five years after liver transplantation based on pretransplant clinical characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Model for end-stage liver disease (MELD) exception for unusual metabolic liver diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Model for end-stage liver disease (MELD) exception for portal hypertensive gastrointestinal bleeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Model for end-stage liver disease (MELD) exception for severe pruritus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Extended donor criteria have no negative impact on early outcome after liver transplantation: a single-center multivariate analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Organ donors: heartbeating and non-heartbeating

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Routine use of livers from deceased donors older than 70: is it justified?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Assignment of steatotic livers by the Mayo model for end-stage liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Use of livers with microvesicular fat safely expands the donor pool

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Factors in association with sepsis after liver transplantation: the Hungarian experience.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Randomized trial of choledochocholedochostomy with or without a T tube in orthotopic liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

T-tube removal after liver transplantation: a new technique that reduces biliary complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Bile duct strictures after liver transplantation: a changing landscape of the Achilles' heel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Natural history of recurrent hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Hepatitis C: magnitude of the problem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Retransplantation for hepatitis C: what do we really know?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Hepatitis C is a risk factor for death after liver retransplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Low risk of hepatitis B virus recurrence after withdrawal of long-term hepatitis B immunoglobulin in patients receiving maintenance nucleos(t)ide analogue therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Antiviral therapy for pre- and post-liver transplantation patients with hepatitis B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Alcohol recidivism impairs long-term patient survival after orthotopic liver transplantation for alcoholic liver disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Recurrent primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis after transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Recurrence of autoimmune liver disease after liver transplantation: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

De novo esophageal neoplasia after liver transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

Nonmelanoma skin cancer after liver transplantation. Study of risk factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

De Novo neoplasia after liver transplantation: an analysis of risk factors and influence on survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

De novo breast cancer in patients with liver transplantation: University of Pittsburgh's experience and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

A 20-year prospective study of cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.09.038

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRANSPROCEED.2009.09.038

1 reference

4 November 2017

1 reference